Finance

Lists
Q1 2027 earnings • released • EPS beat +19.51% • Revenue beat +4.17%
See results
CVSA:NYSE
Covista Inc
$122.68
-1.09%
(-1.35) 1D
Nov 3, 9:40:41 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVSA...
Open
$123.84
High
$125.11
Low
$122.68
Mkt. cap
4.12B
Avg. vol.
346.65K
Volume
7.49K
52-wk high
$142.13
52-wk low
$94.11
Beta
0.70
Shares outstanding
33.26M
No. of employees
5K
Open
$123.84
High
$125.11
Low
$122.68
Mkt. cap
4.12B
Avg. vol.
346.65K
Volume
7.49K
52-wk high
$142.13
52-wk low
$94.11
Beta
0.70
Shares outstanding
33.26M
No. of employees
5K
News stories
From web sources and news partners
Profile
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University. Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026. Wikipedia
About Covista Inc
CEOStephen W. Beard
Employees4.75K
Founded1973
Headquarters-
SectorEducation
Websitecovista.com
Analyst ratings
Based on 4 analysts giving stock ratings to CVSA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CVSA in the last 3 months.
Highest
Current $122.68
$175.00 (+42.65%)
Average
$159.00 (+29.61%)
Lowest
$140.00 (+14.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alexander Paris
Barrington
Buy
Reiterated
$175.00
+42.6%
10/30/2026
Jeffrey Silber
BMO Capital
Buy
Reiterated
$146.00
+19%
10/30/2026
Jack Slevin
Jefferies
Buy
Maintained
$175.00
+42.6%
09/15/2026
Jasper Bibb
Truist Financial
Hold
Downgraded
$140.00
+14.1%
09/03/2026
Last report
Oct 29, 2026
Fiscal period
Q1 2027
$2.19 / $1.83
+19.51%beat
Revenue / Est. (USD)
511.53M / 491.06M
+4.17%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
503.38M
487.03M
501.38M
511.53M
Cost of goods sold
205.42M
210.72M
216.75M
220.76M
Cost of revenue
205.42M
210.72M
216.75M
220.76M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182.79M
184.11M
188.09M
192.58M
Operating expense
182.79M
184.11M
188.09M
192.58M
Total operating expenses
388.22M
394.82M
404.84M
413.34M
Operating income
115.17M
92.20M
96.54M
98.19M
Other non operating income
-
-
-
-
EBT including unusual items
101.90M
77.94M
88.40M
89.50M
EBT excluding unusual items
105.83M
79.06M
88.34M
89.88M
Income tax expense
25.83M
19.96M
16.24M
18.02M
Effective tax rate
25.35%
25.61%
18.37%
20.13%
Other operating expenses
-
-
-
-
Net income
76.38M
41.64M
71.72M
67.43M
Net profit margin
15.17%
8.55%
14.30%
13.18%
Earnings per share
2.43
1.98
2.09
2.19
Interest and investment income
1.57M
481.00K
1.60M
1.63M
Interest expense
-10.92M
-13.63M
-9.80M
-9.94M
Net interest expenses
-9.34M
-13.15M
-8.20M
-8.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
128.93M
106.39M
110.57M
110.45M
Gain or loss from assets sale
2.00K
601.00K
138.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps